A Study of Investigational Dulaglutide Doses in Participants With Type 2 Diabetes on Metformin Monotherapy
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 318 participants.
Also called NCT02973100
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 318 participants
- Sponsor
- Registry
-
NCT02973100 -
2016-002494-34
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, Czechia, Mexico, Poland, Puerto Rico, Romania
- Registry status
- Completed
Technical summary
Registry record NCT02973100. Randomized; double masking; primary purpose treatment. Start 2016-12 (registry gives no type); primary completion 2017-07-15 (actual). Results posted on 2018-08-24.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study of Investigational Dulaglutide Doses in Participants With Type 2 Diabetes on Metformin Monotherapy
- Condition
- Type 2 Diabetes
- Intervention (Drug)
- Dulaglutide
- Intervention (Drug)
- Placebo
- Lead sponsor
- Eli Lilly and Company
Record details
- Record id
cardio:ct-nct02973100- Content hash
ecc2a466d3621d82f9984447d84eddbab66f3f6c2ec57035cad206e70a9ff6a2